The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Short Interest Up 21.0% in October

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) saw a significant increase in short interest in the month of October. As of October 15th, there was short interest totalling 9,800 shares, an increase of 21.0% from the September 30th total of 8,100 shares. Based on an average trading volume of 21,900 shares, the days-to-cover ratio is currently 0.4 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Price Performance

CGABL stock traded up $0.05 during midday trading on Wednesday, reaching $19.88. The stock had a trading volume of 4,024 shares, compared to its average volume of 21,308. The business has a fifty day simple moving average of $19.90 and a two-hundred day simple moving average of $18.90. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a twelve month low of $15.90 and a twelve month high of $20.85.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, November 1st will be given a $0.2891 dividend. The ex-dividend date of this dividend is Friday, November 1st. This represents a $1.16 dividend on an annualized basis and a yield of 5.82%.

About Carlyle Group Inc. 4.625% Subordinated Notes due 2061

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.